Literature DB >> 22820963

Diagnosis and treatment of hand dermatitis.

Afsaneh Alavi1, Sandra Skotnicki, Gordon Sussman, R Gary Sibbald.   

Abstract

PURPOSE: To enhance the learner's competence with knowledge of hand dermatitis. TARGET AUDIENCE: : This continuing education activity is intended for physicians and nurses with an interest in skin and wound care.
OBJECTIVES: After participating in this educational activity, the participant should be better able to: 1. Demonstrate knowledge of the pathophysiology and assessment of, and diagnostic testing for, hand dermatitis. 2. Apply knowledge of hand dermatitis to patient care scenarios for treatment recommendations and patient education. Hand dermatitis is a common disorder with different clinical presentations. Contact (irritant and allergic) dermatitis is the most common subtype with atopic dermatitis and dyshidrotic eczema as common differential diagnoses. The exact diagnosis and differential diagnoses (psoriasis, fungal infections) are important for specific investigations and treatment plans.

Entities:  

Mesh:

Year:  2012        PMID: 22820963     DOI: 10.1097/01.ASW.0000418540.54237.e5

Source DB:  PubMed          Journal:  Adv Skin Wound Care        ISSN: 1527-7941            Impact factor:   2.347


  3 in total

1.  Dyshidrotic eczema following intravenous immunoglobulin treatment.

Authors:  Kachiu C Lee; Barry Ladizinski
Journal:  CMAJ       Date:  2012-12-03       Impact factor: 8.262

Review 2.  Hand dermatitis: an allergist's nightmare.

Authors:  Lindsey Wold; Jennifer K Chen; Heather P Lampel
Journal:  Curr Allergy Asthma Rep       Date:  2014-11       Impact factor: 4.806

3.  IL-24 contributes to skin inflammation in Para-Phenylenediamine-induced contact hypersensitivity.

Authors:  Astrid B Van Belle; Perrine M Cochez; Magali de Heusch; Lisa Pointner; Remi Opsomer; Peggy Raynaud; Younes Achouri; Emilie Hendrickx; Pamela Cheou; Guy Warnier; Jean-Christophe Renauld; Marie Baeck; Laure Dumoutier
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.